Your browser doesn't support javascript.
loading
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial.
Spaas, Mathieu; Sundahl, Nora; Hulstaert, Eva; Kruse, Vibeke; Rottey, Sylvie; De Maeseneer, Daan; Surmont, Veerle; Meireson, Annabel; Brochez, Lieve; Reynders, Dries; Goetghebeur, Els; Van den Begin, Robbe; Van Gestel, Dirk; Renard, Vincent; Dirix, Piet; Mestdagh, Pieter; Ost, Piet.
Afiliación
  • Spaas M; Radiation Oncology, Ghent University Hospital, C. Heymanslaan 10, B-9000, Ghent, Belgium. mathieu.spaas@uzgent.be.
  • Sundahl N; Radiation Oncology, Ghent University Hospital, C. Heymanslaan 10, B-9000, Ghent, Belgium.
  • Hulstaert E; Dermatology, Ghent University Hospital, Ghent, Belgium.
  • Kruse V; Center for Medical Genetics (CMGG), Ghent University, Ghent, Belgium.
  • Rottey S; Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
  • De Maeseneer D; Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
  • Surmont V; Medical Oncology, Ghent University Hospital, Ghent, Belgium.
  • Meireson A; Medical Oncology, Ghent University Hospital, Ghent, Belgium.
  • Brochez L; Medical Oncology, Ghent University Hospital, Ghent, Belgium.
  • Reynders D; Medical Oncology, AZ Sint-Lucas, Bruges, Belgium.
  • Goetghebeur E; Pulmonary Medicine, Ghent University Hospital, Ghent, Belgium.
  • Van den Begin R; Dermatology, Ghent University Hospital, Ghent, Belgium.
  • Van Gestel D; Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
  • Renard V; Dermatology, Ghent University Hospital, Ghent, Belgium.
  • Dirix P; Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
  • Mestdagh P; Department of Applied Mathematics, Computer Science and Statistics & Stat-Gent CRESCENDO Consortium, Ghent University, Ghent, Belgium.
  • Ost P; Department of Applied Mathematics, Computer Science and Statistics & Stat-Gent CRESCENDO Consortium, Ghent University, Ghent, Belgium.
BMC Cancer ; 21(1): 514, 2021 May 07.
Article en En | MEDLINE | ID: mdl-33962592
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ensayos Clínicos Controlados Aleatorios como Asunto / Radiocirugia / Inhibidores de Puntos de Control Inmunológico / Neoplasias Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ensayos Clínicos Controlados Aleatorios como Asunto / Radiocirugia / Inhibidores de Puntos de Control Inmunológico / Neoplasias Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Reino Unido